Document is current
Any future updates will be listed below
-
Authors
Clusmann, Jan http://orcid.org/0000-0003-2925-8438
Kolbinger, Fiona R. http://orcid.org/0000-0003-2265-4809
Muti, Hannah Sophie
Carrero, Zunamys I. http://orcid.org/0000-0001-8501-1566
Eckardt, Jan-Niklas
Laleh, Narmin Ghaffari
Löffler, Chiara Maria Lavinia
Schwarzkopf, Sophie-Caroline
Unger, Michaela http://orcid.org/0000-0001-5811-0200
Veldhuizen, Gregory P.
Wagner, Sophia J.
Kather, Jakob Nikolas
-
Funding
Funding for this research was provided by:
European Union’s Horizon Europe and innovation programme
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 21 September 2023
First Online: 10 October 2023
Competing interests
: The authors declare the following competing interests: J.N.K. declares consulting services for Owkin, France; Panakeia, UK; and DoMore Diagnostics, Norway and has received honoraria for lectures from AstraZeneca, Bayer, Eisai, MSD, BMS, Roche, Pfizer and Fresenius. The other authors declare no competing interests.
